On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

420 with CNW — Many Patients with Breast Cancer Use Marijuana Alongside Meds

Over the past couple of years, cannabis has grown increasingly popular as more states pass legislation to allow either medical marijuana or recreational cannabis. With advocates across the country advocating for state measures and lawmakers discussing federal decriminalization, cannabis has come a long way from the days of prohibition.

As it has slowly shed its unfounded reputation as a destructive drug, cannabis has interestingly moved into the health and wellness space thanks to a diverse range of purported health benefits. By May 2018, more than 3.5 million registered medical marijuana patients existed across the country, with countless more using recreational marijuana to try and alleviate their health issues.

However, despite cannabis’ popularity as a medical alternative, most scientists caution that the hype has far outpaced the science. While marijuana definitely has medical potential, using it as an alternative to pharmaceuticals, especially without the knowledge and permission of a doctor, can be quite dangerous. According to recently published research, such a situation is unfolding in America among individuals suffering from breast cancer. The study, which was published in “Cancer,” an American Cancer Society peer-reviewed journal, found that nearly half of American adults suffering from breast cancer use marijuana alongside their treatment to manage side effects and symptoms.

Various types of cancer and their treatments often cause pain, fatigue, insomnia, nausea and other health issues. Although studies have found that cannabis can indeed alleviate issues such as chronic pain, lack of appetite and insomnia, many physicians are not comfortable discussing it as a treatment option due to the limited knowledge on cannabis’ risks and benefits.

To find the rate of cannabis use among breast cancer patients, the researchers conducted an online survey of 612 participants. An estimated 42% of respondents said they had used cannabis to treat symptoms such as pain, insomnia, anxiety, nausea and vomiting with 75% of those who used cannabis reporting that it was extremely or very helpful.

Disturbingly, 49% of the participants who used marijuana believed medical cannabis could treat cancer, a claim that is still unproven by scientists. Almost 80% of the cannabis users had taken cannabis while undergoing other treatments such as surgery, radiation and systemic therapies. Half of those patients had looked for information on medical cannabis with websites and other patients being the most popular sources of information and physicians being the least popular. Most of the respondents were not satisfied with the information they received on medical cannabis. Furthermore, participants used cannabis products of varying quality and purity, mistakenly assuming that the products were safe and tested.

The researchers concluded that health providers ought to initiate informed conversations about medical marijuana with their patients. The fact that cancer patients are using cannabis without their doctors’ knowledge is a “major blind spot” in ability of health-care providers to provide suitable care, the researchers say. Initiating informed conversations will allow doctors to properly manage the symptoms and side effects of cancer and cancer treatment while minimizing potential side effects and treatment interactions.

The findings that plenty of women are using marijuana alongside their prescription medications seems to reaffirm how much the public has come to trust medicinal cannabis products such as those made by companies such Hero Technologies Inc. (OTC: HENC).

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Archives

Select A Month

Official NewsWire Relationships

Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo USA CBD Expo

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722